{"DataElement":{"publicId":"6576594","version":"1","preferredName":"Gastric Cancer AJCC Edition 8 Clinical Group Stage","preferredDefinition":"Clinical stage group based on the combination of T, N, and M categories and relevant prognostic factors for gastric carcinoma, using AJCC Ed. 8 criteria.","longName":"GAST_AJC8_CLN_STG","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6576372","version":"1","preferredName":"Gastric Neoplasm Clinical Stage Grouping","preferredDefinition":"Relating to the stomach._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","longName":"3443882v1.0:2925061v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"3443882","version":"1","preferredName":"Gastric Neoplasm","preferredDefinition":"Relating to the stomach.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C13307:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric","conceptCode":"C13307","definition":"Relating to the stomach.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE9BBA38-E583-4C0E-E040-BB89AD430CAC","latestVersionIndicator":"Yes","beginDate":"2012-04-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-26","modifiedBy":"ONEDATA","dateModified":"2012-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2925061","version":"1","preferredName":"Clinical Stage Grouping","preferredDefinition":"Having to do with the examination and treatment of patients.:Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C25398:C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FD8E36A-281E-6D78-E040-BB89AD43144A","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7C1FBFC3-46F5-404B-E053-F662850A4BD8","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"TAYLORT","dateModified":"2019-08-30","changeDescription":"12/3/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6576477","version":"1","preferredName":"Gastric Carcinoma American Joint Committee on Cancer Edition 8 Clinical Group Stage","preferredDefinition":"A term that refers to the clinical staging of gastric cancer according to the American Joint Committee on Cancer, 8th edition._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"6576477v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IVB","valueDescription":"Clinical Stage IVB Gastric Cancer AJCC v8","ValueMeaning":{"publicId":"6576479","version":"1","preferredName":"Clinical Stage IVB Gastric Cancer AJCC v8","longName":"6576479","preferredDefinition":"Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage IVB Gastric Cancer AJCC v8","conceptCode":"C133653","definition":"Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C25B130-2478-799D-E053-F662850AA877","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C25B130-2491-799D-E053-F662850AA877","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"IVA","valueDescription":"Clinical Stage IVA Gastric Cancer AJCC v8","ValueMeaning":{"publicId":"6576481","version":"1","preferredName":"Clinical Stage IVA Gastric Cancer AJCC v8","longName":"6576481","preferredDefinition":"Stage IVA includes: (T4b, Any N, M0): T4b: Tumor invades adjacent structures/organs. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage IVA Gastric Cancer AJCC v8","conceptCode":"C133652","definition":"Stage IVA includes: (T4b, Any N, M0): T4b: Tumor invades adjacent structures/organs. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C25B130-249E-799D-E053-F662850AA877","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C25B130-24B7-799D-E053-F662850AA877","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"III","valueDescription":"Clinical Stage III Gastric Cancer AJCC v8","ValueMeaning":{"publicId":"6576483","version":"1","preferredName":"Clinical Stage III Gastric Cancer AJCC v8","longName":"6576483","preferredDefinition":"Stage III includes: (T3, N1, N2, or N3, M0); (T4a, N1, N2, or N3, M0). T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage III Gastric Cancer AJCC v8","conceptCode":"C133650","definition":"Stage III includes: (T3, N1, N2, or N3, M0); (T4a, N1, N2, or N3, M0). T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C25B130-24C4-799D-E053-F662850AA877","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C25B130-24DD-799D-E053-F662850AA877","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Clinical Stage IIB Gastric Cancer AJCC v8","ValueMeaning":{"publicId":"6576485","version":"1","preferredName":"Clinical Stage IIB Gastric Cancer AJCC v8","longName":"6576485","preferredDefinition":"Stage IIB includes: (T3, N0, M0); (T4a, N0, M0). T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage IIB Gastric Cancer AJCC v8","conceptCode":"C133682","definition":"Stage IIB includes: (T3, N0, M0); (T4a, N0, M0). T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C25B130-24EA-799D-E053-F662850AA877","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C25B130-2503-799D-E053-F662850AA877","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Clinical Stage IIA Gastric Cancer AJCC v8","ValueMeaning":{"publicId":"6576487","version":"1","preferredName":"Clinical Stage IIA Gastric Cancer AJCC v8","longName":"6576487","preferredDefinition":"Stage IIA includes: (T1, N1, N2, or N3, M0); (T2, N1, N2, or N3, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage IIA Gastric Cancer AJCC v8","conceptCode":"C133681","definition":"Stage IIA includes: (T1, N1, N2, or N3, M0); (T2, N1, N2, or N3, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C25B130-2510-799D-E053-F662850AA877","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C25B130-2529-799D-E053-F662850AA877","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"I","valueDescription":"Clinical Stage I Gastric Cancer AJCC v8","ValueMeaning":{"publicId":"6576489","version":"1","preferredName":"Clinical Stage I Gastric Cancer AJCC v8","longName":"6576489","preferredDefinition":"Stage I includes: (T1, N0, M0); (T2, N0, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage I Gastric Cancer AJCC v8","conceptCode":"C133648","definition":"Stage I includes: (T1, N0, M0); (T2, N0, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C25B130-2536-799D-E053-F662850AA877","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C25B130-254F-799D-E053-F662850AA877","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"},{"value":"0","valueDescription":"Clinical Stage 0 Gastric Cancer AJCC v8","ValueMeaning":{"publicId":"6576491","version":"1","preferredName":"Clinical Stage 0 Gastric Cancer AJCC v8","longName":"6576491","preferredDefinition":"Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria, high grade dysplasia. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage 0 Gastric Cancer AJCC v8","conceptCode":"C133647","definition":"Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria, high grade dysplasia. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C25B130-255C-799D-E053-F662850AA877","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7C25B130-2575-799D-E053-F662850AA877","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6576476","version":"1","preferredName":"Gastric Cancer by AJCC v8 Clinical Stage Stage Grouping Stage","preferredDefinition":"A term that refers to the clinical staging of gastric cancer according to the American Joint Committee on Cancer, 8th edition.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C133639:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Cancer by AJCC v8 Clinical Stage","conceptCode":"C133639","definition":"A term that refers to the clinical staging of gastric cancer according to the American Joint Committee on Cancer, 8th edition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C25B130-244C-799D-E053-F662850AA877","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"ONEDATA","dateModified":"2018-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7C25B130-245D-799D-E053-F662850AA877","latestVersionIndicator":"Yes","beginDate":"2018-12-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-03","modifiedBy":"TAYLORT","dateModified":"2019-08-30","changeDescription":"8/30/19 TMT released per MC.; 12/3/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"10000182","version":"1","longName":"Stomach","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Clinical disease stage","type":"Preferred Question Text","description":"Clinical disease stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7C33A755-DD4A-7668-E053-F662850A0C21","latestVersionIndicator":"Yes","beginDate":"2018-12-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-04","modifiedBy":"TAYLORT","dateModified":"2019-08-30","changeDescription":"8/30/19 TMT released per MC.; 12/4/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}